Neuroscientists at King's College London have pinpointed a mechanism behind the increased neural connectivity observed in the very early stages of Alzheimer's disease. Published in Translational ...
Dr. Hope Rugo explains how antibody-drug conjugates like Datroway and Trodelvy are shifting the treatment landscape for ...
If you're considering the med for weight loss, read this first.
Zacks Investment Research on MSN
INCY wins EC approval for label expansion of oncology drug Zynyz
Incyte INCY recently announced that the European Commission has approved a label expansion of oncology drug Zynyz ...
A “significant number of patients” could see a cure for multiple myeloma within the next two decades, one expert told ...
A sweeping review of dozens of clinical trials suggests that today’s most widely used GLP-1 receptor agonist drugs produce broadly consistent weight-loss results across age, race, ethnicity, and ...
Lots of people are talking about peptides. But what are they? Here’s a quick primer on the health trend and what we know about peptides’ safety.
Teclistamab plus daratumumab and hyaluronidase-fihj is approved for relapsed or refractory MM after one prior line of therapy, including a proteasome inhibitor and immunomodulatory agent.
Voluntary MFN commitments by 16 manufacturers reportedly cover ~70% of Medicare drug spending, potentially obviating GUARD/GLOBE finalization while avoiding predictable legal challenges. Lindsay ...
Colorectal cancer is one of the cancers where, if found early, it has a 91% chance of survival for the patient. If you find ...
At least 111 substances of unknown safety have been added to foods, drinks and supplements sold in the United States without ...
But the FDA’s decision does not preclude CMS from determining that the higher dose is not reasonable and necessary — ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results